Applicability of three nutritional screening tools in patients with liver cirrhosis under the Global Leadership Initiative on Malnutrition criteria

Abstract

Objective To investigate whether Royal Free Hospital Nutritional Prioritizing Tool (RFH-NPT) is more suitable than Nutritional Risk Screening 2002 (NRS-2002) in nutritional risk screening for patients with liver cirrhosis, as well as the applicability of subjective global assessment (SGA) in the nutritional assessment of patients with liver cirrhosis. Methods A total of 113 patients with liver cirrhosis who were hospitalized in Renmin Hospital of Wuhan University from August 2020 to June 2021 were enrolled. RFH-NPT and NRS-2002 were used for nutritional risk screening, and SGA was used for nutritional assessment. The results of these tools were compared with the Global Leadership Initiative on Malnutrition (GLIM) criteria, and sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV) were calculated for the three tools. The receiver operating characteristic (ROC) curve was plotted and the area under the ROC curve (AUC) was calculated for each screening tool, and the association between nutritional status and short-term prognosis was analyzed. The independent samples t-test or the Mann-Whitney U test was used for comparison of continuous data between two groups, and the chi-square test was used for comparison of categorical data between two groups. The Spearman correlation analysis was used to analyze the correlation of GLIM criteria with NRS2002, RFH-NPT and SGA. Results According to the GLIM criteria, 69.9% of the patients were diagnosed with malnutrition, and RFH-NPT and NRS2002 screened out that 72.6% and 51.3%, respectively, of the patients had nutritional risk, while SGA assessment showed that 57.5% of the patients had malnutrition. Compared with NRS2002, RFH-NPT had a higher degree of correlation with the GLIM criteria (r=0.764, P < 0.001), higher sensitivity (94.9%) and NPV (87.1%), and a better predictive value (AUC=0.872, 95% confidence interval [CI]: 0.786-0.957). Under the GLIM criteria, SGA had good specificity (88.2%) in the diagnosis of malnutrition in patients with liver cirrhosis, with fair sensitivity (77.2%), good correlation (r=0.607, P < 0.001), and good predictive value (AUC=0.827, 95%CI: 0.744-0.911). Based on the GLIM criteria, SGA assessment, and RFH-NPT assessment, the patients with nutritional risk or malnutrition tended to have a longer length of hospital stay (Z=-3.301, -2.812, and -3.813, all P < 0.05) and a higher rehospitalization rate (χ²=3.957, 6.922, and 6.766, all P < 0.05). Based on the GLIM criteria and NRS2002 assessment, the patients with nutritional risk or malnutrition had a significant increase in mortality rate within 3 months (χ²=4.511 and 0.776, both P < 0.05). Conclusion Under the GLIM criteria, RFH-NPT is more suitable than NRS2002 for nutritional risk screening of patients with liver cirrhosis, and SGA also has good applicability in nutritional assessment of patients with liver cirrhosis. In addition, GLIM criteria, SGA, and RFH-NPT are associated with the clinical outcome of patients.
- Liver Cirrhosis,
- Malnutrition,
- RFH-NPT,
- NRS2002,
- SGA

FullText(HTML)

References(27)

References

[1]	KUFTINEC G, RAM BHAMIDIMARRI K, PEARLMAN M. Malnutrition in Cirrhosis: Frequent but overlooked[J]. Liver Transpl, 2019, 25(12): 1743-1744. DOI: 10.1002/lt.25660.
[2]	MAHARSHI S, SHARMA BC, SRIVASTAVA S. Malnutrition in cirrhosis increases morbidity and mortality[J]. J Gastroenterol Hepatol, 2015, 30(10): 1507-1513. DOI: 10.1111/jgh.12999.
[3]	SHIN S, JUN DW, SAEED WK, et al. A narrative review of malnutrition in chronic liver disease[J]. Ann Transl Med, 2021, 9(2): 172. DOI: 10.21037/atm-20-4868.
[4]	PLAUTH M, BERNAL W, DASARATHY S, et al. ESPEN guideline on clinical nutrition in liver disease[J]. Clin Nutr, 2019, 38(2): 485-521. DOI: 10.1016/j.clnu.2018.12.022.
[5]	BORHOFEN SM, GERNER C, LEHMANN J, et al. The royal free hospital-nutritional prioritizing tool is an independent predictor of deterioration of liver function and survival in cirrhosis[J]. Dig Dis Sci, 2016, 61(6): 1735-1743. DOI: 10.1007/s10620-015-4015-z.
[6]	ZHANG YH, YANG X, ZHANG D, et al. Application of subjective global nutritional assessment in patients with hepatitis-B-related liver cirrhosis[J]. Parenter Enteral Nutr, 2016, 23(6): 329-331. DOI: 10.16151/j.1007-810x.2016.06.0031. 张颖慧, 杨雪, 张笛, 等. 主观综合性评估乙型肝炎性肝硬化病人的营养状况[J]. 肠外与肠内营养, 2016, 23(6): 329-331. DOI: 10.16151/j.1007-810x.2016.06.0031.
[7]	CEDERHOLM T, JENSEN GL, CORREIA M, et al. GLIM criteria for the diagnosis of malnutrition-A consensus report from the global clinical nutrition community[J]. J Cachexia Sarcopenia Muscle, 2019, 10(1): 207-217. DOI: 10.1002/jcsm.12383.
[8]	THEILLA M, RATTANACHAIWONG S, KAGAN I, et al. Validation of GLIM malnutrition criteria for diagnosis of malnutrition in ICU patients: An observational study[J]. Clin Nutr, 2021, 40(5): 3578-3584. DOI: 10.1016/j.clnu.2020.12.021.
[9]	HENRIQUE JR, PEREIRA RG, FERREIRA RS, et al. Pilot study GLIM criteria for categorization of a malnutrition diagnosis of patients undergoing elective gastrointestinal operations: A pilot study of applicability and validation[J]. Nutrition, 2020, 79-80: 110961. DOI: 10.1016/j.nut.2020.110961.
[10]	Chinese Society of Hepatology, Chinese Medical Association. Chinese guidelines on the management of liver cirrhosis[J]. J Clin Hepatol, 2019, 35(11): 2408-2425. DOI: 10.3969/j.issn.1001-5256.2019.11.006. 中华医学会肝病学分会. 肝硬化诊治指南[J]. 临床肝胆病杂志, 2019, 35(11): 2408-2425. DOI: 10.3969/j.issn.1001-5256.2019.11.006.
[11]	European Association for the Study of the Liver. EASL clinical practice guidelines on nutrition in chronic liver disease[J]. J Hepatol, 2019, 70(1): 172-193. DOI: 10.1016/j.jhep.2018.06.024.
[12]	KONDRUP J, RASMUSSEN HH, HAMBERG O, et al. Nutritional risk screening (NRS 2002): A new method based on an analysis of controlled clinical trials[J]. Clin Nutr, 2003, 22(3): 321-336. DOI: 10.1016/s0261-5614(02)00214-5.
[13]	AMODIO P, BEMEUR C, BUTTERWORTH R, et al. The nutritional management of hepatic encephalopathy in patients with cirrhosis: International Society for Hepatic Encephalopathy and Nitrogen Metabolism Consensus[J]. Hepatology, 2013, 58(1): 325-336. DOI: 10.1002/hep.26370.
[14]	CIOCÎRLAN M, CAZAN AR, BARBU M, et al. Subjective global assessment and handgrip strength as predictive factors in patients with liver cirrhosis[J]. Gastroenterol Res Pract, 2017, 2017: 8348390. DOI: 10.1155/2017/8348390.
[15]	Chinese Society of Hepatology, Chinese Society of Gastroenterology, Chinese Medical Association. Clinical guidelines on nutrition in end-stage liver disease[J]. J Clin Hepatol, 2019, 35(6): 1222-1230. DOI: 10.3969/j.issn.1001-5256.2019.06.010. 中华医学会肝病学分会, 中华医学会消化病学分会. 终末期肝病临床营养指南[J]. 临床肝胆病杂志, 2019, 35(6): 1222-1230. DOI: 10.3969/j.issn.1001-5256.2019.06.010.
[16]	BUCHARD B, BOIRIE Y, CASSAGNES L, et al. Assessment of malnutrition, sarcopenia and frailty in patients with cirrhosis: Which tools should we use in clinical practice?[J]. Nutrients, 2020, 12(1): 186. DOI: 10.3390/nu12010186.
[17]	ZHANG X, TANG M, ZHANG Q, et al. The GLIM criteria as an effective tool for nutrition assessment and survival prediction in older adult cancer patients[J]. Clin Nutr, 2021, 40(3): 1224-1232. DOI: 10.1016/j.clnu.2020.08.004.
[18]	KOOTAKA Y, KAMIYA K, HAMAZAKI N, et al. The GLIM criteria for defining malnutrition can predict physical function and prognosis in patients with cardiovascular disease[J]. Clin Nutr, 2021, 40(1): 146-152. DOI: 10.1016/j.clnu.2020.04.038.
[19]	BOULHOSA R, LOURENÇO RP, CÔRTES DM, et al. Comparison between criteria for diagnosing malnutrition in patients with advanced chronic liver disease: GLIM group proposal versus different nutritional screening tools[J]. J Hum Nutr Diet, 2020, 33(6): 862-868. DOI: 10.1111/jhn.12759.
[20]	BOJKO M. Causes of sarcopenia in liver cirrhosis[J]. Clin Liver Dis (Hoboken), 2019, 14(5): 167-170. DOI: 10.1002/cld.851.
[21]	ZHANG XN, JIANG ZM, WU HS, et al. NRS 2002 nutritional risk screening and GLIM step 2 for diagnosis of malnutrition (without FFMI currently)[J]. Chin J Clin Nutr, 2020, 28(1): 1-6. DOI: 10.3760/cma.j.cn115822-20190923-00141. 张献娜, 蒋朱明, 吴河水, 等. NRS2002营养风险筛查暨GLIM第二步诊断营养不良(目前不用肌肉量理由)[J]. 中华临床营养杂志, 2020, 28(1): 1-6. DOI: 10.3760/cma.j.cn115822-20190923-00141.
[22]	SINCLAIR M. Controversies in diagnosing sarcopenia in cirrhosis-moving from research to clinical practice[J]. Nutrients, 2019, 11(10): 2454. DOI: 10.3390/nu11102454.
[23]	GUO Y, TANG ZQ. Progress on the application of detection and assessment tools for deficiency of liver cirrhosis[J/CD]. Chin J Liver Dis (Electronic Version), 2020, 12(1): 1-5. DOI: 10.3969/j.issn.1674-7380.2020.01.001. 郭艳, 唐中权. 肝硬化营养不良检测手段与评估工具应用进展[J/CD]. 中国肝脏病杂志(电子版), 2020, 12(1): 1-5. DOI: 10.3969/j.issn.1674-7380.2020.01.001.
[24]	TRAUB J, BERGHEIM I, HORVATH A, et al. Validation of malnutrition screening tools in liver cirrhosis[J]. Nutrients, 2020, 12(5): 1306. DOI: 10.3390/nu12051306.
[25]	WU Y, ZHU Y, FENG Y, et al. Royal Free Hospital-Nutritional Prioritizing Tool improves the prediction of malnutrition risk outcomes in liver cirrhosis patients compared with Nutritional Risk Screening 2002[J]. Br J Nutr, 2020, 124(12): 1293-1302. DOI: 10.1017/S0007114520002366.
[26]	ALLARD JP, KELLER H, GRAMLICH L, et al. GLIM criteria has fair sensitivity and specificity for diagnosing malnutrition when using SGA as comparator[J]. Clin Nutr, 2020, 39(9): 2771-2777. DOI: 10.1016/j.clnu.2019.12.004.
[27]	MOCTEZUMA-VELAZQUEZ C, EBADI M, BHANJI RA, et al. Limited performance of subjective global assessment compared to computed tomography-determined sarcopenia in predicting adverse clinical outcomes in patients with cirrhosis[J]. Clin Nutr, 2019, 38(6): 2696-2703. DOI: 10.1016/j.clnu.2018.11.024.

Relative Articles

[1]	Jiongjiong BI, Yingjie MA. Characteristics of the composition of intestinal flora in cirrhotic patients with malnutrition[J]. Journal of Clinical Hepatology, 2024, 40(1): 83-88. doi: 10.12449/JCH240115
[2]	Nan GENG, Ming KONG, Yu CHEN, Zhongping DUAN. Association between portal hypertension and malnutrition in liver cirrhosis[J]. Journal of Clinical Hepatology, 2023, 39(9): 2205-2209. doi: 10.3969/j.issn.1001-5256.2023.09.026
[3]	Honglin MA, Jing YANG, Qiu JIN, Run LUO, Jiao LENG, Xia WANG. Current status of research on nutritional support in end-stage liver disease[J]. Journal of Clinical Hepatology, 2022, 38(1): 215-219. doi: 10.3969/j.issn.1001-5256.2022.01.038
[4]	Yumei HE, Liping WU, Zhiming WANG, Menghao HAO, Ling HU, Jiazhen LI, Xiaobin SUN. Research progress in nutritional support for liver cirrhosis patients[J]. Journal of Clinical Hepatology, 2022, 38(12): 2846-2849. doi: 10.3969/j.issn.1001-5256.2022.12.031
[5]	Yijun ZHANG, Qian ZHANG, Xinhua LUO. Assessment and clinical management of malnutrition and asthenia in patients with liver cirrhosis[J]. Journal of Clinical Hepatology, 2022, 38(7): 1646-1649. doi: 10.3969/j.issn.1001-5256.2022.07.035
[6]	Chinese Society of Nutritional Oncology, Chinese Society for Parenteral and Enteral Nutrition. Expert opinion on nutritional treatment for patients with biliary tract tumors[J]. Journal of Clinical Hepatology, 2021, 37(9): 2058-2061. doi: 10.3969/j.issn.1001-5256.2021.09.011
[7]	Bo GAO, Yuzheng ZHUGE. Malnutrition in liver cirrhosis: Benefits from improving portal hypertension[J]. Journal of Clinical Hepatology, 2021, 37(12): 2767-2769. doi: 10.3969/j.issn.1001-5256.2021.12.005
[8]	Dandan JIA, Guiying ZHU, Shiyao LIAO, Hui ZHANG, Hui GUO, Lili YANG, Changmiao WANG. Interpretation of European Society for Clinical Nutrition and Metabolism practical guideline : Clinical nutrition in liver disease (2020)[J]. Journal of Clinical Hepatology, 2021, 37(7): 1553-1557. doi: 10.3969/j.issn.1001-5256.2021.07.015
[9]	Xiaoting SONG, Wentao XU, Yu CHEN, Xingshun QI. An excerpt of malnutrition, frailty, and sarcopenia in patients with cirrhosis: 2021 practice guidance by the American Association for the Study of Liver Diseases[J]. Journal of Clinical Hepatology, 2021, 37(12): 2787-2789. doi: 10.3969/j.issn.1001-5256.2021.12.011
[10]	Huijuan XIAO, Tao HAN. Prevention and treatment of malnutrition, sarcopenia, and osteoporosis in patients with liver cirrhosis[J]. Journal of Clinical Hepatology, 2021, 37(1): 26-30. doi: 10.3969/j.issn.1001-5256.2021.01.006
[11]	Xiao HuiJuan, Qi YuMei, Han Tao. An excerpt of ESPEN guideline on clinical nutrition in liver disease (2019)[J]. Journal of Clinical Hepatology, 2019, 35(5): 968-972. doi: 10.3969/j.issn.1001-5256.2019.05.007
[12]	Ma Bao, Deng Yong, Wang ZhiXin, Wang HaiJiu, Fan HaiNing. A preliminary study of the pathogenesis of malnutrition in patients with hepatic alveolar echinococcosis[J]. Journal of Clinical Hepatology, 2018, 34(1): 204-206. doi: 10.3969/j.issn.1001-5256.2018.01.045
[13]	Zhu BingHua, Zhao ZhangQing, Zhou Yang, Xu LieMing. A nutritional risk screening model for patients with liver cirrhosis established using discriminant analysis[J]. Journal of Clinical Hepatology, 2017, 33(6): 1106-1111. doi: 10.3969/j.issn.1001-5256.2017.06.018
[14]	Zhu Bin, Zou CongCong, Zheng Xin. Malnutrition assessment and nutrition support therapy for end-stage liver disease[J]. Journal of Clinical Hepatology, 2017, 33(9): 1699-1706. doi: 10.3969/j.issn.1001-5256.2017.09.014
[15]	Gan XueMei, Li Wu. Nutrition support therapy for patients with hepatic encephalopathy[J]. Journal of Clinical Hepatology, 2016, 32(1): 178-181. doi: 10.3969/j.issn.1001-5256.2016.01.039
[16]	Zhang HuiKai, Meng XiangLin, Li HaiLei, Xu YuLing, Luo HongWei. Current status of malnutrition and its association with prognosis in hospitalized patients with decompensated liver cirrhosis[J]. Journal of Clinical Hepatology, 2016, 32(6): 1100-1103. doi: 10.3969/j.issn.1001-5256.2016.06.015
[17]	Zhang Jian. Correlation between malnutrition and prognosis of hepatitis A in Uygur children[J]. Journal of Clinical Hepatology, 2015, 31(8): 1235-1237. doi: 10.3969/j.issn.1001-5256.2015.08.013
[18]	Zhang Min, Hang Lei, Yuan XiaoJie, Yan HongQing. Observation of dietary intervention on nutritional risk in patients with liver cirrhosis[J]. Journal of Clinical Hepatology, 2014, 30(8): 764-767. doi: 10.3969/j.issn.1001-5256.2014.08.016
[19]	Wang MaoRong. Paying attention to nutritional management of hepatic encephalopathy in patients with liver cirrhosis: introduction to ISHEN consensus[J]. Journal of Clinical Hepatology, 2013, 29(9): 649-651. doi: 10.3969/j.issn.1001-5256.2013.09.004

Supplements(0)

Cited By

Cited by

Periodical cited type(6)

1.	严兆兰. 青海地区乙型肝炎肝硬化并发轻微肝性脑病Stroop测试及诱发疾病危险因素调查分析. 中华养生保健. 2024(22): 84-86 .
2.	符健，高艺，林锋，李盼盼. 海口地区轻微肝性脑病PHES标准参考值范围的研究. 海南医学. 2023(13): 1903-1907 .
3.	樊亚楠，纪童童，梁荣月，于岩岩，徐京杭. 肝硬化合并显性肝性脑病危险因素的回顾性分析：一项单中心病例对照研究. 中华肝脏病杂志. 2021(02): 133-136 .
4.	边倩，解新科，寇小妮，李京涛，魏海梁，闫曙光. 通腑降浊汤联合乳果糖治疗热扰心神型肝性脑病临床观察. 山东中医杂志. 2021(06): 577-582 .
5.	覃秀容，陈月桥，石清兰，毛德文. 轻微肝性脑病的中西医研究进展. 中医药导报. 2020(12): 152-156 .
6.	王琳. 疏肝解郁胶囊治疗伴抑郁焦虑的肝性脑病患者的效果. 国际精神病学杂志. 2019(05): 925-928 .

Other cited types(1)

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Figures(1) / Tables(5)

Get Citation

PDF

XML

Article Metrics

Article views (1072) PDF downloads(107)

Applicability of three nutritional screening tools in patients with liver cirrhosis under the Global Leadership Initiative on Malnutrition criteria

DOI: 10.3969/j.issn.1001-5256.2022.02.019